I would like to see a brighter light shone on 'user fees', which is a mechanism for the pharma companies to 'expedite' approval of their products by making payments directly to the FDA. This is a poor incentive structure.
[FDA budget](https://crsreports.congress.gov/product/pdf/R/R44576)
dantzler /
npub1jm…aukpd
2023-01-27 19:02:11
in reply to nevent1q…s9cz
Author Public Key
npub1jmr7lf85239hswjhy6jxrq2hf8cteelkddl855shfd23564ajxeseaukpdPublished at
2023-01-27 19:02:11Event JSON
{
"id": "b2dfd00a57ab39f9c7c6d7d068b00e1c505335f8bb8a814feb70988bedf79cc5",
"pubkey": "96c7efa4f4544b783a5726a461815749f0bce7f66b7e7a52174b551a6abd91b3",
"created_at": 1674846131,
"kind": 1,
"tags": [
[
"p",
"0d8c556f4f8580508a057ee24000ab63aef89ae2c3efdc8018ae4d2c73dfd4d7",
"wss://nostr-pub.wellorder.net"
],
[
"e",
"fc155fa46e17cad8475c80f9d0400ff7ff3fd7def08d95ca8382731291373d74",
"wss://nostr.zebedee.cloud",
"root"
],
[
"e",
"a3b9c8f6cbc812394f9efd0459181bc2a29539cd958ecdfdf2390b494ae299c7",
"wss://relay.nostr.info",
"reply"
]
],
"content": "I would like to see a brighter light shone on 'user fees', which is a mechanism for the pharma companies to 'expedite' approval of their products by making payments directly to the FDA. This is a poor incentive structure.\n\n\n[FDA budget](https://crsreports.congress.gov/product/pdf/R/R44576)",
"sig": "a811dd15212e7351fba8fe7da278511de0b452a3ff4fb6a258d17d4a067bfb4d45927d33c33247c433fcc559416d257385f62e80d75915abbd6808e12ae73b12"
}